Search results
Japan's Otsuka Pharma-Lundbeck Partnered Depression Drug Gets FDA Approval For Alzheimer's Agitation
Benzinga via Yahoo Finance· 12 months agoOtsuka Pharmaceutical Co Ltd (OTC: OTSKF) (OTC: OTSKY) (Otsuka) and H. Lundbeck A/S have received...
FDA clears first digital treatment for depression, but experts caution that research is still early
CNN via Yahoo News· 1 month agoThe US Food and Drug Administration is allowing the use of Rejoyn, the first prescription digital...
Vanguard Health Care Fund's Strategic Moves: Spotlight on Ono Pharmaceutical Co Ltd
GuruFocus.com via Yahoo Finance· 5 months agoInsight into the Fund's Latest Investment Decisions and Portfolio Adjustments Vanguard Health Care...
Japan's Otsuka Pharma gets FDA approval for Alzheimer's agitation drug
Reuters via Yahoo News· 12 months agoPatients with Alzheimer's sometimes show signs of extreme aggression or become restless and anxious...
27 Largest Biotech Companies in the US
Insider Monkey via Yahoo Finance· 1 year agoIn this article, we take a look at 27 largest biotech companies in the US. You can skip our detailed analysis of the biotech industry and go directly to...
Aurinia Pharmaceuticals Inc (AUPH) Reports 60% Increase in Q3 Net Product Revenue
GuruFocus.com via Yahoo Finance· 6 months agoNet product revenue of $40.8 million for Q3 2023, a 60% increase over Q3 2022 Total net revenue of $130.4 million for the nine months ended September 30, 2023, a 24% increase over the same period ...
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q4 2022 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 year agoAurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q4 2022 Earnings Call Transcript February 28, 2023...
FDA Clears the First Prescription App for Depression
Verywell Health via Yahoo News· 4 weeks agoPhoto Illustration by Amelia Manley for Verywell Health; Rejoyn Fact checked by Nick Blackmer Key Takeaways The FDA has cleared a prescription mobile app...
COMPASS Pathways plc (CMPS) Q2 2022 Earnings Call Transcript
Motley Fool· 2 years agoAgain, my name is Steve Schultz, senior vice president of investor relations at COMPASS Pathways....
Clerkenwell Health raises £2.1M to test the new wave of psychedelics treatments
TechCrunch· 2 years agoClerkenwell Health, a psychedelic-specialist clinical research organisation, has raised £2.1 million...